ストックスクリーナーアプリを入手
5.90
2.61%
0.15
アフターアワーズ：
5.90
前日終値:
$5.75
開ける：
$5.7
24時間の取引高:
961.04K
Relative Volume:
0.67
時価総額：
$472.55M
収益：
-
当期純損益:
$-168.09M
株価収益率:
-2.7189
EPS:
-2.17
ネットキャッシュフロー:
$-138.01M
1週間 パフォーマンス:
+4.80%
1か月 パフォーマンス:
-19.07%
6か月 パフォーマンス:
-67.39%
1年 パフォーマンス:
-67.20%
1日の値動き範囲:
$5.64
$5.91
1週間の範囲:
$5.50
$6.11
52週間の値動き範囲:
$5.41
$23.48
Kura Oncology Inc Stock (KURA) Company Profile
名前
Kura Oncology Inc
セクター
電話
(858) 500-8800
住所
12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA
KURA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KURA
Kura Oncology Inc
|
5.90 | 472.55M | 0 | -168.09M | -138.01M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Kura Oncology Inc Stock (KURA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-06 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-10-24 | 開始されました | UBS | Buy |
| 2024-10-14 | ダウングレード | Stifel | Buy → Hold |
| 2023-12-22 | 開始されました | Mizuho | Buy |
| 2023-08-11 | 開始されました | BofA Securities | Buy |
| 2023-07-27 | 開始されました | Scotiabank | Sector Perform |
| 2023-05-17 | 開始されました | BTIG Research | Buy |
| 2023-01-31 | 開始されました | Stifel | Buy |
| 2022-07-12 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-02-15 | 開始されました | Jefferies | Buy |
| 2021-05-05 | 再開されました | Credit Suisse | Outperform |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2020-12-07 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-12-03 | 開始されました | Stifel | Buy |
| 2020-11-05 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | 開始されました | Credit Suisse | Outperform |
| 2020-05-05 | 開始されました | Barclays | Overweight |
| 2019-07-18 | 開始されました | Deutsche Bank | Buy |
| 2018-11-09 | 開始されました | Piper Jaffray | Overweight |
| 2018-08-01 | 開始されました | H.C. Wainwright | Buy |
| 2016-10-13 | 再開されました | Leerink Partners | Outperform |
| 2016-01-22 | 開始されました | JMP Securities | Mkt Outperform |
| 2015-12-30 | 開始されました | Oppenheimer | Outperform |
| 2015-12-16 | 開始されました | Citigroup | Buy |
すべてを表示
Kura Oncology Inc (KURA) 最新ニュース
Kura Oncology, Inc. (NASDAQ:KURA) Shares Acquired by Vanguard Group Inc. - Defense World
American Century Companies Inc. Increases Stake in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World
Corebridge Financial Inc. Reduces Position in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World
Kura Oncology (NASDAQ:KURA) Earns Outperform Rating from Wedbush - Defense World
KLP Kapitalforvaltning AS Acquires New Position in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World
Kura Oncology stock holds $28 target, Market Outperform By Investing.com - Investing.com Canada
Kura Oncology's SWOT analysis: ziftomenib potential drives stock outlook - Investing.com
Kura Oncology’s SWOT analysis: ziftomenib potential drives stock outlook By Investing.com - Investing.com South Africa
Kura Oncology, Inc. (NASDAQ:KURA) Given Average Recommendation of “Moderate Buy” by Brokerages - The AM Reporter
Kura Oncology, Inc. (NASDAQ:KURA) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Kura Oncology at Stifel Forum: Strategic Moves in Targeted Therapies By Investing.com - Investing.com Canada
Kura Oncology Submits Ziftomenib NDA to FDA for Treating Acute Myeloid Leukemia - MarketScreener
Kura Oncology and Kyowa Kirin Announce Submission of New Drug Application for Ziftomenib to FDA - The Manila Times
Kura Oncology seeks FDA approval for leukemia drug - Investing.com
Kura Oncology seeks FDA approval for leukemia drug By Investing.com - Investing.com India
Breakthrough Cancer Drug for AML Reaches Major FDA Milestone: First-in-Class Treatment - Stock Titan
Kura Oncology stock hits 52-week low at $5.65 amid market challenges By Investing.com - Investing.com South Africa
Kura Oncology stock hits 52-week low at $5.65 amid market challenges - Investing.com India
28,748 Shares in Kura Oncology, Inc. (NASDAQ:KURA) Purchased by Thrivent Financial for Lutherans - Defense World
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Kura Oncology Strengthens Team: Strategic Stock Options Awarded to New Hires - Stock Titan
Kura Oncology (NASDAQ:KURA) Upgraded to “Buy” at StockNews.com - Defense World
Corient Private Wealth LLC Makes New $109,000 Investment in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World
Kura Oncology, Inc. (NASDAQ:KURA) Shares Bought by Teacher Retirement System of Texas - Defense World
Kura Oncology to Participate in Stifel Targeted Oncology Forum - The Manila Times
Kura Oncology CEO Set to Reveal Latest Cancer Treatment Strategy at Elite Stifel Forum - Stock Titan
Kura Oncology stock hits 52-week low at $6.75 amid market challenges - Investing.com India
Virtu Financial LLC Acquires New Position in Kura Oncology, Inc. (NASDAQ:KURA) - The AM Reporter
Virtu Financial LLC Makes New Investment in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World
Kura Oncology (NASDAQ:KURA) Upgraded by StockNews.com to “Buy” Rating - The AM Reporter
Kura Oncology (NASDAQ:KURA) Upgraded by StockNews.com to Buy Rating - Defense World
Kura Oncology presents promising preclinical data By Investing.com - Investing.com South Africa
Kura Oncology presents promising preclinical data - Investing.com India
Kura Oncology Announces Preclinical Data for KO-2806 Selected for Oral Presentation at the 2025 AACR Annual Meeting - The Manila Times
Charles Schwab Investment Management Inc. Buys 10,542 Shares of Kura Oncology, Inc. (NASDAQ:KURA) - Defense World
Kura Oncology director Hasnain Faheem sells $181,456 in shares By Investing.com - Investing.com Australia
Insider Sell: Faheem Hasnain Sells 22,682 Shares of Kura Oncology Inc (KURA) - GuruFocus
Kura Oncology director Hasnain Faheem sells $181,456 in shares - Investing.com
Bank of New York Mellon Corp Decreases Stock Position in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World
Brokers Issue Forecasts for Kura Oncology FY2025 Earnings - Defense World
Kura Oncology (NASDAQ:KURA) Downgraded by StockNews.com to “Hold” - Defense World
US Bancorp DE Has $193,000 Stake in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World
Kura Oncology, Inc. (NASDAQ:KURA) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
BTIG Research downgrades Kura Oncology Inc (KURA) stock to a Neutral - Knox Daily
Kura Oncology Inc (KURA) Q4 2024 Earnings: EPS of -$0.22 Beats E - GuruFocus.com
Kura Oncology at Leerink Conference: Strategic Advances in AML Therapies By Investing.com - Investing.com UK
Kura Oncology at Leerink Conference: Strategic Advances in AML Therapies - Investing.com
Kura Oncology stock hits 52-week low at $6.98 amid challenges - Investing.com Australia
Kura Oncology stock hits 52-week low at $6.98 amid challenges By Investing.com - Investing.com South Africa
Recent Research Analysts’ Ratings Changes for Kura Oncology (KURA) - Defense World
Kura Oncology Inc (KURA) 財務データ
収益
当期純利益
現金流量
EPS
2.51%
大文字化:
|
ボリューム (24 時間):